25 Patent Results (14 families)
Make Note

Activation And Expansion Of T-cells Using An Engineered Multivalent Signaling Platform

  • Published: Dec 29, 2009
  • Filed: Jun 13, 2003
  • Earliest Priority: Jan 03 2002
  • Family: 2
  • Cited Works: 106
  • Cited by: 16
  • Cites: 38
  • Additional Info: Cited Works Full text Published
  • Owner: Pennsylvania University Of
  • Applicant: Univ Pennsylvania
Granted Patent
US 7638326 B2
008-454-429-288-930

Activation And Expansion Of T-cells Using An Engineered Multivalent Signaling Platform

  • Published: Dec 29, 2009
  • Filed: Jan 3, 2003
  • Earliest Priority: Jan 03 2002
  • Family: 8
  • Cited Works: 106
  • Cited by: 16
  • Cites: 38
  • Additional Info: Cited Works Full text Published
  • Owner: Trustees Of The University Of Pennsylvania The
  • Applicant: Univ Pennsylvania
Granted Patent
US 7638325 B2
090-300-526-408-887

Activation And Expansion Of T-cells Using An Agent That Provides A Primary Activation Signal And Another Agent That Provides A Co-stimulatory Signal

  • Published: Mar 2, 2010
  • Filed: Jan 3, 2003
  • Earliest Priority: Jan 03 2002
  • Family: 8
  • Cited Works: 100
  • Cited by: 7
  • Cites: 38
  • Additional Info: Cited Works Full text Published
  • Owner: Pennsylvania University Of The Trustees Of The, Trustees Of The University Of Pennsylvania The
  • Applicant: Univ Pennsylvania
Granted Patent
US 7670781 B2
091-452-747-033-299

Interleukin-2 Stimulated T Lymphocyte Cell Death For The Treatment Of Autoimmune Diseases, Allergic Responses, And Graft Rejection

  • Published: Jul 4, 2000
  • Filed: Sep 15, 1993
  • Earliest Priority: Aug 28 1991
  • Family: 2
  • Cited Works: 57
  • Cited by: 25
  • Cites: 3
  • Additional Info: Cited Works Full text Published
  • Applicant: Us Health
Granted Patent
US 6083503 A
110-095-960-830-064

Superantigen Agonist And Antagonist Peptides

Granted Patent
US 5859207 A
059-507-635-626-474

Modified Myelin Basic Protein Molecules

  • Published: May 9, 2006
  • Filed: May 2, 1995
  • Earliest Priority: May 02 1995
  • Family: 2
  • Cited Works: 108
  • Cited by: 0
  • Cites: 10
  • Sequences: 27
  • Additional Info: Cited Works Full text Published Sequence
  • Owner: Alexion Pharmaceuticals Inc, Health And Human Services Department Of United States Of America The As Represented By The Secretary
  • Applicant: Alexion Pharma Inc
Granted Patent
US 7041503 B2
114-711-959-461-259

Superantigen Agonist And Antagonist Peptides

  • Published: Aug 13, 1996
  • Filed: Mar 29, 1994
  • Earliest Priority: Sep 08 1992
  • Family: 2
  • Cited Works: 24
  • Cited by: 32
  • Cites: 0
  • Sequences: 10
  • Additional Info: Cited Works Full text Published Sequence
  • Owner: University Of Florida
  • Applicant: Univ Florida
Granted Patent
US 5545716 A
094-848-237-545-18X

Vertebrate Apoptosis Gene: Compositions And Methods

Granted Patent
US 6911532 B2
099-236-429-108-616

Vertebrate Apoptosis Gene: Compositions And Methods

  • Published: Jul 8, 1997
  • Filed: Jun 22, 1993
  • Earliest Priority: Jun 22 1993
  • Family: 17
  • Cited Works: 26
  • Cited by: 42
  • Cites: 1
  • Sequences: 8
  • Additional Info: Cited Works Full text Published Sequence
  • Owner: Regent Of The University Of Michigan The, Arch Development Corporation
  • Applicant: Univ Michigan, Arch Dev Corp
Granted Patent
US 5646008 A
112-250-953-179-496

Vertebrate Apoptosis Gene: Compositions And Methods

Granted Patent
US 6303331 B1
101-324-019-812-037
{{::'analysis.preview.CITED_WORKS_ANALYSIS.title' | message}} {{::'analysis.preview.view.full' | message}}

Add New Note

Sorry, you can't add a note to multiple items. You can add a note to your search as a saved query. Did you want to save this search and add a note to it?

Cancel Save
Search ORCID

Sign in to the Lens

Forgot Password? Register New Account
Feedback